KU Cancer Center

vice-chancellor of KU Cancer Center’s Clinical Trials Office, Natalie Streeter

New assistant vice-chancellor of KU Cancer Center’s Clinical Trials Office, Natalie Streeter, discusses the latest in breakthrough clinical trials and cancer research.

 At any given time, The University of Kansas Cancer Center is managing about 600 clinical trials across the cancer continuum, with approximately 250 of those trials actively enrolling participants.

KUCC Faith Works

The KU Cancer Center is working with Faith Works, a consortium of researchers and church leaders, to spread the word about the importance of cancer prevention and screenings among the African American community.

African Americans have the highest death rate and shortest survival rate for most cancers of any racial or ethnic group in the U.S. That’s why scientists at The University of Kansas Cancer Center are working hard to overcome these hurdles, and they’re doing it in a unique way.

NCI map

The University of Kansas Cancer Center is the only NCI-designated cancer center in the region.

Team members at The University of Kansas Cancer Center are busy preparing their application for National Cancer Institute (NCI) designation renewal, a prestigious distinction held by only 70 other cancer centers in the United States.

Teri Banman, RN

Teri Banman, RN, oversees the Nurse Navigator Program at the KU Cancer Center, which pairs trained oncology nurses with patients to help guide them and their families through their cancer journeys.

When confronting cancer, it can be overwhelming to consider treatment options and discover clinical trial opportunities. That’s where a KU Cancer Center nurse navigator can help. 

Branda new lab coat crop

Joaquina Baranda, M.D., leads the KU Cancer Center’s early-phase clinical trial program, which is the first step in taking new therapies from the research lab to the patient

Decades of basic (or bench) science has built the foundational knowledge needed to make advancements in the diagnosis, treatment and prevention of diseases, including cancer. That preclinical research has led to early-phase clinical trials and today’s leading-edge cancer treatments at The University of Kansas Cancer Center.